Related Experiment Video
Updated: Aug 6, 2026

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
Published on: September 18, 2017
Decreased cardiac sarcoplasmic reticulum Ca2+ -ATPase activity contributes to cardiac dysfunction in
Xiao-Yan Zhao1, Shen-Jiang Hu, Jiang Li
1Institute of Cardiology, The First Affiliated Hospital, China.
Insights
Diabetic cardiomyopathy involves impaired heart muscle function. This study found reduced sarcoplasmic reticulum Ca2+-ATPase activity and cardiac dysfunction in diabetic rats, linked to increased phospholamban levels.
Area of Science:
- Cardiology
- Endocrinology
- Molecular Biology
Background:
- Diabetic cardiomyopathy is a distinct cardiac complication of diabetes mellitus.
- It is characterized by impaired myocardial contractility, independent of vascular disease.
- Sarcoplasmic reticulum Ca2+-ATPase (SERCA) plays a crucial role in cardiac muscle relaxation and contraction.
Purpose of the Study:
- To investigate the alterations in cardiac sarcoplasmic reticulum Ca2+-ATPase activity and cardiac function in streptozotocin-induced diabetic rats.
- To determine the role of phospholamban in the pathogenesis of diabetic cardiomyopathy.
Main Methods:
- Diabetes mellitus was induced in male Wistar rats using streptozotocin.
- Cardiac function was assessed by measuring left ventricular hemodynamic parameters (LVEDP, LVSP, +/- dP/dtmax).
- Sarcoplasmic reticulum Ca2+-ATPase activity, phospholamban mRNA, and protein levels were quantified at 4, 6, and 8 weeks post-induction.
Main Results:
- At 6 and 8 weeks, diabetic rats exhibited significantly decreased sarcoplasmic reticulum Ca2+-ATPase activity and impaired cardiac function.
- Elevated phospholamban mRNA and protein levels were observed in diabetic rats at these time points.
- No significant changes in sarcoplasmic reticulum Ca2+-ATPase protein levels were found, suggesting post-translational regulation or altered activity.
Conclusions:
- Sarcoplasmic reticulum Ca2+-ATPase activity is depressed in streptozotocin-induced diabetic rats.
- Increased phospholamban protein levels contribute to the pathogenesis of cardiac dysfunction in diabetic cardiomyopathy.
- These findings highlight a key molecular mechanism underlying diabetic heart disease.
Abstract:
Diabetic cardiomyopathy is characterized by reduced cardiac contractility due to direct changes in myocardium function independent of vascular disease. This study is to investigate the alterations of cardiac sarcoplasmic reticulum Ca2+ -ATPase activity and cardiac function in streptozotocin-induced diabetic rats. Diabetes mellitus (DM) was induced in male Wistar rats by intraperitoneal injection of streptozotocin. The activity of myocardium sarcoplasmic reticulum Ca2+ -ATPase and the left ventricular hemodynamic parameters were measured in DM rats 4 weeks, 6 weeks and 8 weeks after streptozotocin was administered. Phospholamban mRNA expression was detected by reverse transcription-polymerase chain reaction, and the protein levels of phospholamban and sarcoplasmic reticulum Ca2+ -ATPase were determined by Western blot. Normal rats served as control group. It was found that in DM rats 4 weeks after streptozotocin injection, the cardiac function, myocardium sarcoplasmic reticulum Ca2+ -ATPase activity, phospholamban mRNA and phospholamban protein were not significantly changed compared with those in the control rats. At 6 and 8 weeks after the streptozotocin injection, DM rats showed a significant decrease in sarcoplasmic reticulum Ca2+ -ATPase activity and cardiac function, as indicated by an increase of LVEDP and a marked depression in LVSP and +/- dP/dtmax. At the same time points, increases in phospholamban mRNA and protein levels were observed in DM rats. Sarcoplasmic reticulum Ca2+ -ATPase protein level showed no significant alterations in all DM rats compared with that in control rats. Our work confirms that sarcoplasmic reticulum Ca2+ -ATPase activity is depressed in rats with streptozotocin-induced DM, which is accompanied by elevated phospholamban protein level thus contribute to the pathogenesis of cardiac dysfunction in diabetic rats.
Related Concept Videos
Diabetic Nephropathy
Type II Diabetes II: Pathophysiology
Heart Failure II: Pathophysiology
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Diabetic Retinopathy

